Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

Table 6 Clinical Outcome of non-diabetes subjects based on MAGE levels during in-hospital and 30-day follow-up

MAGE (mmol/L)		<2.21	2.21-3.38	>3.38	P
Subject number (n)	164	55	55	54	NA
Composite MACE	17 (10.4)	4 (7.3)	6 (10.9)	7 (13)	0.614
Non-IRA revascularization	26 (15.9)	7 (12.7)	9 (16.4)	10 (18.5)	0.704

Data given as mean ± SD or n (%).
MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.

ISSN: 1758-5996